Where To Invest Your Money Now September 21, 2015

options trading service

Where To Invest Your Money Now 

Read the September 21, 2015 Where To Invest Your Money Now Newsletter in .pdf format – Click Here

September 21, 2015

Market Strategies Newsletter

Sample Issue

Balanced Investing Strategies To Make Money In Up Or Down Markets

A Publication of Princeton Research, Inc. (www.PrincetonResearch.com)

Contributing Staff: Michael King, Charles Moskowitz

Where To Invest Your Money Now

Where To Invest In 2015 Newsletter Covering:


Where to Invest September 2015

Best Stocks To Buy September 2015

Stock Market Investing Strategies

Stock Options Trade Alerts

Options Trading Strategies

How To Trade Options



$180 Profits This Week


2015 YTD Profits $ 7691

Over 76% Returns


2014 Profits = $ 20,443

Over 204% Returns


NOTE: This is a Sample Issue Only!



Visit: PrincetonResearch.com/join.htm


For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm


Charles Moskowitz Discussion


We Have 2 Open Positions:


ETSY October 15 Calls and

XLE Sept 63 Puts


Funds in Use: $ 1188


Week 38 was another quiet one for us.  We only had one closing trade for a profit of $180.

This brings YTD return up to $7680 or almost 77%.  We have one long (ETSY and one short (XLE) using a total of $1,188.


I found this week especially interesting from the standpoint of opinions that I heard on CNBC. The inclusion of the words “global weakness” as an excuse to not raise rates is of concern because it has nothing to do with Feds dual mandate on our economy.  Looking at employment and inflation makes some sense but his is clearly an overreach by the Fed.  It simply puts more uncertainty here at home.


Another issue that will rear its ugly head this month is the shutdown of the government over the funding of Planned Parenthood.  I know it seems to be another singular issue but make no mistake, with the heating up of the primary races there is more at stake for the candidates who won’t, or can’t back down.  Personally, I would give the odds that it is less than a 20% chance that the politicians can come to an agreement.  Remember that when this happened before we got the “sequester.”  It is a major issue to close the government.


I saw an interview with Jamie Dimon this morning on Meet the Press, and I think he hit the nail on the head….”Government gridlock and shutdowns are a failure in management.”  He also made a point when asked about the Chinese owning so much of our debt by explaining that they own roughly $1.6 Trillion of the treasuries….but the economy is worth $100 Trillion…..really not so bad.


Speaking about the primaries, if they traded them I’d have to short Trump and Ben Carson, buy the Fiorina calls, short Bernie and buy the Hillary calls.  There is so much attention being paid to what really is the undercard.  Primaries are nothing like the general election when everyone rushes to the middle to get the moderates votes.


As for the markets, October is usually an ugly month with an ugly history.  But it is also a month that has proven to be one that gives us both a bottom and a setup for the year end rally.  I have been harping on the lack of growth in the top line for almost 2 years.  I really didn’t need Bob Pisani of CNBC to chime in on Friday afternoon to validate my belief that that’s really “not a good thing.”


The S&P500 got right back up to 2020, its point of breakdown and was again turned lower.  If this ascending wedge fails (and it is really close) we will have to test 1910.  A close below 1913.85 will send us back to test 1867 and then 1820.  If we can get some more sideways action between 1920 and 1875, we could see an October bottom that takes us back to test 2100.  While these are not staggering numbers, you have to remember that these kind of moves used to take 6-9 months to develop.


These days with the volatility we have they can occur in a matter of just weeks.



Where to invest in 2015

Market Strategies $10,000 Trading Account Trade Table                               

Bought 4 XLE September 25th 63 Puts
Bought 8 ETSY October 15 Calls
Sold 4 YRWC September 17.50 Puts
     180 Gain
Bought 4 YRWC Sept 17.50 Puts

Remember, these trades are based on your participation in the

Subscriber Members Only




Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.


For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm

Where To Invest Now Investing StrategiesMARKET Laboratory –Weekly Changes

Prices are copied from Barron’s Weekly and Yahoo Finance and may be incorrect.








S&P 500








Russell 2000








Gold (spot)












Heating Oil




Unleaded Gas




Natural Gas








Put/Call Ratios

S&P 100



Put/Call Ratios

CBOE Equity





155-24  +30

2.93% -0.03%

10 Yr. Note

127-31 +14         2.13% -06%






CRB Inflation





Barron’s* Confidence







5 Yr. Note

120-034 +122

1.43% -0.08%






DJ Utilities








33.3 %








M1 Money  Supply


Sept 7th

M-2 Money



Sept 7th

* Component Change in the Confidence Index

M1…all money in hands of the public, Time Deposits Traveler’s Checks, Demand Deposits
M2.. adds Savings and Money Market Accounts both compared with the previous year.

how to invest $10000

Market Strategies Technical Information

                              Support/Resistance Levels:                SUPPORT                         RESISTANCE


S&P 500            1930                                   1987

Dow                15,980                                16,640

QQQ           102.00                                105 60

Transports         7880                                  8177

NASDAQ           4690                               4840



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm


$100,000 Trading Portfolio Stock Positions and Trades

Each stock is allocated a theoretical $ 5,000 share of the portfolio unless otherwise indicated.  




Purchase Price Purchase Date Stop/Loss   Price/Date Sold   Profit/


MOS  100 43.55       08/14
SNSS 1200   2.95       06/26        0.98
DSX  500   7.05       05/18
CRM  100 72.90       04/29      66.25
GILD  50 102.73       03/03    100.45
ARRY 500   8.02       02/24        5.12
NAT   300

Sold 200

10.16       02/13 14.40  06/25    $ 848
NBG  600 1.40       02/17
BAC. Wts 5,000 lots 0.7411       12/26
BSBR  500






SAN  600 8.40      12/16
AA  500 14.21      10/16
FCX 150 34.99      09/09    7.75
NBG 300   2.95      05/19
RPTP 200

Sold 200

15.37      01/16 16.09  06/25   $ 144
NBG 300 4.08 8/12
TEXQY* 200 6.56 7/11
REPR* 5000 0.22 10/22/12


Remember, these trades are based on your participation in the

Subscriber Members Only


Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.

For those of you who do not buy puts to protect your portfolio, there are many ETF’s that are the inverse of the DOW. The symbols are DOG, DXD, SDS,TZA and RWM, which go up when the  DOW, S&P 500 and Russell 2000 go down and down when they go up. The DZZ goes up double when gold goes down.



Market Strategies $100,000 Trading Account


There was one closed option position; YRCW September 17.50 Puts making a profit of $ 360.


There were no closed out stock positions.


For the year to date we have gains of $ 21,756. 


Open position losses increased to $ 17,414.


The options expire on the third Friday of each Month unless otherwise posted.


The Stock table has the following 19 positions:





The options call for a $ 2,500 investment unless otherwise stated; each stock position requires $5,000 unless otherwise mentioned specifically


We are basing money management on a hypothetical

$ 100,000 and are using a total of

$   64,735 for the 19 open stock positions.  There are two long option positions requiring

$     2,376 totaling

$   67,111 leaving

$   32,889 in cash.


These figures are approximate and there might be errors.


We have not counted the dividends received from Apple, JP Morgan, North American Tankers,

Santander, their Brazil affiliate BSBR and  Blue Capital Reinsurance which was sold for a profit

and many others.


Executions that have occurred at or near the open or close of trading sometimes vary from our actual numbers.  For example, when something opens down and it is through our price, we take the next trade whether it is an uptick or continues lower.  This sometimes results in a 50% trade that is slightly above or below the exact number.



Previous Week’s Recommendations and

Rules for the Market Strategies

$100,000 Portfolio Trading Account


  • All options count for about $ 2,500.00 for model portfolio calculations unless

otherwise stated


  • When the option has doubled sell half the position


  • Stop Loss protection is either half or offered with each trade


  • The cost of the option is the asking price (or the price between the bid and ask,

whichever is more realistic)


  • The options will be followed until closed out.


  • Option Symbols are stock symbol with expiration month and strike price


Option                                       Cost                   Date           Sold   Date Profit/(Loss)
XLE Sept25th63                        Puts

8 lots                                           1.17

ETSY Oct 10th 15                     Calls

6 lots                                           0.90

YRCW Sept 17.50                     Calls

8 lots                                           1.55

8/31/2015 2.00 09/15/2015 $ 360


Remember, these trades are based on your participation in the

Subscriber Members Only


Where To Invest October 2015


Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.


For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm


This Weeks’ Economic Numbers

Earnings Releases and Media Data


Before the Open on top of the Row; After the close below the Economics Information


MONDAY Lennar LEN ( 0.79 vs 0.78 ) Neogen NEOG ( 0.27 vs 0.24 )


10:00 hrs Existing Home Sales August ( 5.50Mln vs 5.59Mln )


Red Hat RHT RHT ( 0.44 vs 0.41 )  Thor Industries THO ( 1.31 vs 1.25 )

TUESDAY AutoZone  AZO ( 12.70 vs 11.28 ) CarMax KMX ( 0.76 vs 0.64 )  ConAgra CAG ( 0.40 vs 0.39 )  Darden Restaurants DRI ( 0.57 vs 0.32 ) Carnival  CCL 1.63 vs 1.58

General Mills GIS ( 0.69 vs 0.61 )

09:00 hrs  FHFA Housing Price Index July ( NA vs 0.2% )

Copart CPRT ( 0.38 vs 0.39 )

WEDNESDAY Advanced Drainage Systems WMS ( 0.36 )

The Federal Reserve’s Federal open Market Committee begins a two-day meeting.

Both Radio Shack and Patriot Coal seek bankruptcy court approval to repay creditors and restructure.

07:00 hrs  MBA Mortgage Index  09/19   ( NA vs -7.0% )

10:30 hrs  Crude Inventories 09/19 ( NA vs  -2.104 Mln Bbls )


Jabil Circuit JBL ( 0.44 vs 0.05 ) Steelcase SCS ( 0.33 vs 0.27 ) Worthington WOR

( 0.51 vs 0.65 ) H.B. Fuller FUL ( 0.70 vs 0.42 ) Aviat Systems AVNW 000 vs -0.13

THURSDAY Accenture  ACN  ( 1.12 vs 1.08 )  KB Home  KBH   ( 0.22 vs 0.28 )

08:30 hrs Initial Claims 09/19  ( 271K vs  264K )

08:30 hrs Continuing Claims 09/12  ( 2248K vs 2237K )

08:30 hrs Durable Goods Orders August ( -2.0% vs 2.2% )

Durable Goods Orders ex-Transportation ( 0.2% vs 0.4% )

10:00 hrs New Home Sales August (  515K vs 507K  )

10:30 hrs Natural Gas Inventories 09/19  ( NA vs 73 bcf )

Bed Bath & Beyond BBBY ( 1.21 vs 1.17 )  Cintas CTAS ( 0.91 vs  0.78 ) NIKE NKE ( 1.19 vs 1.09 ) Pier 1 Imports  PIR  ( 0.07 vs 0.10 ) Radiant  Logstcs  RLGT ( 0.03 )

FRIDAY Blackberry BBRY ( -0.09 vs -0.02 ) Finish Line FINL ( 0.57 vs 0.54 )

08:30 hrs GDP-Third Estimate 2nd Qtr ( 3.7% vs 3.7% )

Implicit Price Deflator 2nd Qtr ( 2.1% vs 2.1% )

10:00 hrs Michigan Sentiment Final for  September ( 87.0 vs 85.7 )



NOTE: This is a Sample Issue Only!



Visit: PrincetonResearch.com/join.htm




For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm


Market Strategies Fundamentals


Stocks fell last week reversing the 2% rise that had been reached prior to the Federal Reserve’s Open Market Committee meeting. The S&P 500 had reached 2020.86, on the day of the meeting  only to close  the week  with a loss collapsing  to 19 58.03 down -3.02  points or 0.15%. The Dow which had been up to 16,674.74 just after the announcement  but reversed course selling off and ending the week with a loss  at 16,384.58, off 48.51 or 0.30 but down  290 points from the highs reached on the same volatile day. The Nasdaq,  which had been as high as 4819 still closed ahead on the week at 4827.23, a slim gain up 4.89 or 0.10%. The Dow Jones Transportation average ended the week at 8036.37, off 15.25 or 0.19%. The Russell 2000 was the only other index in the black for the week gaining 5.55 points to close at 1163.35, up 5.55 points or 0.48%. The Tranny at least had been above its 50-day moving average two days last week, more than could be said for the other indexes.


The market’s reaction to the Fed’s efforts to keep rates low became clearly negative focusing on poor economic growth in the rest of the world and its possible negative impact on  the U.S. economy and large multinational corporate earnings. Nonetheless, the Fed followed through on its promise that it would like to see more evidence of inflation to trigger a rate hike. It’s good to know exactly who you’re dealing with and bad to keep second-guessing an entity as powerful as the Fed.


Treasuries got a continued lift on Friday encouraged by a steep decline in global equity prices and oil. The primary beneficiary was the long end of the curve ,  Gold also got a nice boost   gaining $ 34.50  or 3.1%, while Silver added $ 0.658 cents per ounce or 4.5%.


The Dollar Index fell as low as 94.10 overnight,  but recovered its losses and moved into the green to trade up 1.1% from the low  to close at 95.15 just about unchanged for the week.

The Fed’s policy statement noted that recent global economic and financial developments may somewhat restrain economic activity and are likely to put further downward pressure on inflation over the near term. The Fed meeting was also accompanied by the release of a Summary of Economic Projections. Some notable and perhaps worrisome revisions were made to U.S growth and inflation forecasts when compared to June’s projections. Growth projections for 2016 and 2017 were modestly lowered.  Fed Chair Janet Yellen said that the Fed’s overall outlook hasn’t changed significantly, and that the majority of participants still believe an increase in 2015 will be appropriate. She also again stressed that the long-term policy is more important than the first increase, and in that regard, policy is expected to remain “accommodative” for a long time.

Asian markets held their ground early Friday morning.  It was the European opening that found no support plummeting  the S&P futures 30.5 points lower to 1949.5. The S&P recovered during the U.S. session to gain back  9.00  S&P points to close at 1958. Chinese markets were  only slightly lower on the week as the Direxion ETF ( YINN: 19.09 ) was down  0.13 or 0.7% on the week. However, on a very positive and  bullish note,  the Indian Wisdom Tree ETF(  EPI: 19.70 ) was up 1.4% last week bucking the U.S. and world-wide deluge in stock prices. India is not subject to commodity weakness reflected in currencies like Brazil and Nigeria or growth destabilization such as China and is likely to continue to outperform emerging markets.


Market Strategies Economic Data


All the economic reports last week were disappointing:


The week began with Retail Sales disappointing increasing just 0.2% which was 0.1% lower than expected by Briefing.com. Then the Empire Manufacturing report for September was reported at a minus 14.7. Briefing.com had expected a lower but positive number. Industrial Production declined 0.4% in August . Briefing expected a decline of just -0.2%.Capacity Utilization fell 0.2% to to 77.6%. Even the Conference Board’s Leading Economic Index was up 0.1% less than the plus 0.2% expected.

The Philadelphia Fed’s Business Outlook Survey declined to -0.6 in September from 8.3 in August. The briefing.com Consensus expected the index to increase to 6.5. That was the first reported contraction in the Philadelphia region since February 2014. Surprisingly, just about all of the August regional Federal reserve manufacturing surveys were negative..

he pullback in industrial production came as a result of motor vehicle assemblies returning to more normal trends. In July, assemblies rose to 13.38 mln annualized from 11.81 mln . That was the most vehicles assembled since November 1978. Assemblies in August fell back to 11.78 mln, which lopped off 0.4 percentage points of industrial production growth. Overall, manufacturing production declined 0.5% in August after increasing 0.9% in July. Durable goods manufacturing declined 0.9%, almost all of which can be attributed to a 6.4% decline in motor vehicles and parts production. Nondurable goods manufacturing production was flat.



A positive note  concerning Leading Economic Indicators is with the Coincident Indicators which are comprised of four: the number of employees on non-agriculture payrolls; Personal Income; Index of Industrial production and Personal Income. There are seven Lagging Indicators: Average Prime Rate; Inventories/Sales Ratio; Duration of Unemployment; Labor costs relative to production; CPI; Installment Credit/ Personal Income and Commercial and industrial Loans.


The Four Coincident Indicators continue gaining on the Seven Lagging indicators which is a long term positive.



Market Strategies Cycles


Finally we have our answer. The September FOMC meeting has come and gone and interest rates remain unchanged, exactly the same place they have been since the Fed took emergency action at the start of the financial crisis in December 2008, lowering rates 0 to 0.25%. Primary justifications for not starting to hike rates were tepid inflation (and inflation expectations) along with mounting pressures to growth from outside the U.S. Choppy markets are  expected to remain until conditions stabilize. At that point we expect to be able to buy for the upcoming “ Best 6 Months” November through May.”  

Many stocks have been declining since May but their decline has been masked by the market-capitalization-weighted performance of the S&P 500. The broad sector called “Information Technology” is 20% of the S&P.  Apple is the biggest constituent. Through July 21 this year, when the rest of the market began to exert a pull on even the Fabulous Five, Apple (NASDAQ:AAPL) was up 22%, Facebook (NASDAQ:FB) was up 28%, Google (NASDAQ:GOOG) (NASDAQ:GOOGL) was up 29%, Amazon (NASDAQ:AMZN) was up 65%, and Netflix (NASDAQ:NFLX) was up 138%. Faith based companies can really skew the index!

Airlines, benefitting from lower oil prices,  have also been strong which has held up the transportation Index. Alaska Airlines ( ALK: $ 78.74 ) is up 18% since June 9th. Southwest airlines ( LUV $ 39.47 )  is up 14.5%; Delta airlines ( DAL: $ 46.67 ) + 14.6%  while United Airlines ( UAL: $ 60.31 ) is up 14.7%. all over the same period.

But they can’t forever hide the underlying weakness. The Relative Strength Index ( RSI ) measures the velocity and magnitude of price movements. It is a simple indicator that basically compares the number of higher closes to lower closes of the market, forgetting all the intraday noise. The signal that emerges of late is that it has just violated its channel on the downside (more S&P days closing lower than higher.) This is a bearish indicator. The inverse ETF  HDGE: ( $ 11.11 ) we have recommended for hedging positions is shown in the lower table on page 16. We are long that theoretically at 11.04. Closes above the 200 day price moving average at 11.21 and  the 13-day M.A. just above that would be bullish for the HDGE, bearish for stocks..

The HDGE has not yet been convincing either way but it remains an inexpensive hedge. Other reverse ETF’s are as follows:  the ( SDS: 22.49 ) an Ultra Short S&P 500 ETF; an Ultra  Short Russell 2000, the ( TWM 39.12 ). The Russell tends to be bullish when interest rates are coming down as has been the case recently;  the ( EEV: 23.50 ) Ultra Short MSCI emerging markets and the Direxion Daily CSI 300 China A Shares ( CHAD: 51.81 ) a 1x market. They go higher when their peer group declines.

. MACD Seasonal Buy Signal Update

The Stock Trader’s Seasonal MACD Buy signal cannot likely trigger until October 1 or later. Presently, the MACD Buy indicators have not yet performed in the charts of DJIA, S&P 500 and NASDAQ. They have been slightly positive  since the markets partially bounced back from the  precipitous mid-August decline. Stochastic and relative strength indicators have also been improving since the start of September however, the market’s upward climb has slowed and could eventually falter as it digests the latest developments from the Fed and abroad.


As a result of international developments, tepid growth and inflation estimates the projected path of a higher Fed funds rate has also moved out on the timeline. Four Fed members  even now  believe the appropriate timing for policy tightening is in 2016 and beyond. This Fed inspired uncertainty now is in disfavor with the markets even though higher interest rates are not helpful either.


At this juncture, the market’s reaction to the announcement has been mixed. Initially negative, then positive and negative to end the trading day. Arguably, any positive economic benefits of near-zero rates have likely been exhausted after nearly seven years. New uncertainty has been presented to the markets by way of lower commodity prices led by declines in crude oil and metal prices. Australia, Brazil and Nigeria have seen their currencies collapse amid heightened economic uncertainty  and  pronounced weakness especially  in crude and  iron ore.


Despite the recent downdraft in stock prices, including the Indian markets which have taken a drubbing, the Wisdom Tree India earnings Index on the annual screening date ( August 31,



Crude prices tend to peak along with the end of summer. Driving season and hurricane problems tend to come to an end which is an obstacle to demand while supple continues to abound. Seasonal direction is highlighted in yellow


The weak period for crude is just beginning  and could be the catalyst  for lower stock prices.as evidenced by the chart  below.




Shorting the February crude oil futures contract in mid-September and holding until on or about December 9 has produced 21 winning trades in the last 32 years. This gives the trade a 65.6% success rate and theoretical total gains of $99,860 per futures contract. Following three consecutive years of losses, this trade has been successful for three years straight.



NOTE: This is a Sample Issue Only!



Visit: PrincetonResearch.com/join.htm


 For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm



Undervalued Small Cap Stocks


Repro-Med Systems, Inc ( OTCQX:  REPR 0.31 )* 


RERP is now a member of the OTCQX, a leading U.S. Stock Exchange.


Repro-Med Systems is a unique U.S. manufacturer of proprietary and patented medical  devices  world-wide which maintains offices and manufacturing facilities in Chester, NY.  Principal products include  the Freedom 60 Syringe Infusion System, RMS High-Flo Subcutaneous Safety Needle Sets and the RES-Q-VAC Medical Suctioning Pump. In addition to being regulated by the FDA which has the authority to approve medical devices for marketing in the U.S., RMS complies with ISO International standards for quality development and manufacturing. RMS Medical Products is a d/b/a of Repro-Med Systems, Inc which was founded in 1980.


The Freedom60 has a proprietary technology that makes it desirable for the delivery of medications In a variety of  therapies.  It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “ dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept. This minimizes complications often encountered with other infusion systems which can lead to site reactions and discomfort for the patient. The portability and simple operation of the FREEDOM60 Improves quality of life for patients who otherwise might have to use a complicated electronic pump mounted to a cumbersome infusion pole. Patients then don’t have to be confined.


RMS High-Flo Subcutaneous Safety Needle Sets are being welcomed by healthcare providers and patients alike for their consistently high quality. The infusion sets are an ideal companion for the company’s FREEDOM 60 pump. The needle sets are patented and approved by the FDA. There has not been a new technology in needles other than Repro Med’s vastly better needle sets in quite some time.


RES-Q-VAC is a hand-held suction pump used to clear a patient’s airway or for other purposes when reliable hospital quality suctioning is needed. It uses patented technology to protect users from airborne pathogens and spillage of suctioned material. It is used by emergency service personnel and other first responders, as well as in hospitals and other institutions. There also is a version for use by dentists. RES-Q-VAC is invaluable in the event  of disasters where power is lost because it doesn’t require electricity.


The Freedom 60 Syringe Infusion System is a method for administering medication through a small needle to the subcutaneous tissue, which is the fatty tissue just under the skin. Subcutaneous infusion allows medication into the vascular system more slowly. Combined with more frequent delivery this provides more consistent and stable blood levels. The elimination of large swings in these levels decreases side effects improving overall quality of life. RMS provides High-Flo needles to optimize liquid flow. Their smaller 26 gauge high flow needle flows at the same rate as the considerably larger 24 gauge needles,  which are considerably less painful when entering the skin.


The Freedom 60 has had great success in Europe reflected in a huge sales increase  of  47.8% first quarter 2015 up from same quarter 2014.


Repro-Med Systems, Inc has had an increase in sales each of the last four years. They finished the year of 2014 with $ 11.2 million in sales reflecting top line growth of  29% from 2013.In each of the previous two years they had a 12% increase in sales. The company has had at least $ 700 thousand of net income in each of the past four years and has no debt. The patented needle sets alone can give the company a huge growth potential. In my opinion, with new products coming on stream, the stock should trade between $ 3 and $ 8 in the next two years.




Immune Therapeutics, Inc. (  IMUN 0.19  )* Buy now. IMUN  

Naltrexone is an opioid antagonist used primarily in the management of alcohol and opioid dependence; the FDA approved Naltrexone in 1984 at 50mg. However, in much lower doses there is “Accumulating evidence suggests LDN can promote health supporting immune-modulation, which reduces various oncogenic inflammatory autoimmune processes.

The value of Naltrexone as an immune modulator was recognized by Dr. Ian Zagon at the University of Pennsylvania.2,3 The late Dr. Bernard Bihari, a Neurophysician from New York, USA (who passed away on May 16th, 2010) began treating his patients in the late 1980s4,5. Since that time, many doctors throughout the United States prescribe LDN for a number of indications including Multiple Sclerosis (MS), Parkinson’s disease, Crohn’s disease, HIV/AIDS, cancer and other autoimmune and inflammatory diseases.

A number of research and clinical trials have been completed and undergone in regards to LDN immunotherapies, with phase I and phase II clinical trials successfully run at a number of universities in the United States and Europe, including Pennsylvania State University Medical School at Hershey; University of Chicago; State University of New York; SUNY Upstate Medical University; London Health Sciences Centre – University Hospital, USA; Alpert Medical School of Brown University; Department of Neurology, San Raffaele Scientific Institute; Division of Rheumatology, St. Louis College of Pharmacy; Department of Internal Medicine, University of Utah; Jondi-Shapoor University of Medical Sciences; Department of Psychiatry & Behavioral Sciences, Duke University Medical Center; and Multiple Sclerosis Center at UCSF6. These efforts were pioneered by leading immunologists Dr. Nicholas Plotnikoff, Dr. Ronald Herberman, Dr. Bernard Bihari, Dr. Angus Dalgleish, Dr. Ian S. Zagon, Dr. Jill Smith, Dr. McLaughlin, Dr. Jacqueline McCandless, and Moshe Rogosnitzky, among others.


The mechanism of action of naltrexone, in autoimmune diseases and cancer, is still being researched, but there are theories as to the mechanism of action that both explain why LDN works on both autoimmune diseases and cancers, as well as inflammatory disease.

According to Mark J. Donahue’s paper on LDN that uses interviews from Dr. David, Gluck, Dr. Jacquelyn McCandless, Dr. Jarred Younger, and Dr. Ian Zagon:

“LDN is an opioid antagonist that not only blocks the reception of opiates, but also the body’s own endogenous opioids – endorphins. However, because LDN is administered in such a ‘low dose’ it is believed that LDN only briefly (for 3-4 hours) obstructs the effects of endorphins. Sensing an endorphin deficit, the hypothalamus signals for increased production of endorphins in what is called ‘the rebound effect.’ The rebound effect results in three things happening:

The study of immune cell glial interactions is in its infancy. Glial cells are the immune cells in your central nervous system (brain, spinal cord). They are very involved in dysregulation of pain systems, neuroinflammation, and some neurological diseases such as Multiple Sclerosis, Alzheimer’s, Parkinson ’s disease, Autism, ALS, infections of the brain.

LDN has treated Crohn’s Disease, HIV/Aids, Multiple Sclerosis, Autism, Fibromyalgia, Prostate Cancer, Hepatoblastoma, Gastrointestinal Disorders, Melanoma, Gulf War Syndrome , based on clinical studies and patient data.

Recently the company received it’s first  license to sell their drug in Nigeria. The potential revenues could be just in Nigeria alone over 50 million plus. . There world -wide potential is unlimited and could exceed 2-3 hundred million in the next few years.  This stock has tremendous potential and we believe could trade easily over one dollar per share by the end of 2015.


Enzo Biochem ( ENZ  3.04 )  Bought at our price of  $ 2.78.


This turbulent market has had an effect on the price of Enzo Biochem. The markets, in my opinion, have been in a rotating correction and in some instances, a bear market for some months. It appears that the cause of this is China but I am sure that there are other factors. If you remember the ‘flash crash” of 2010  the market correction was over quickly and those that held through that market decline profited handsomely over the years after the crash. I think that the market is giving us another chance to buy Enzo Biochem at a bargain price. The Company’s fiscal year was over July 31. I would imagine the Quarter and Year results will be made available by mid-October. With the cash settlement in two litigations the cash position should show a major improvement. Top line revenues should also show an improvement. Depending on R&D expenses and litigation expenses the net loss should also show improvement. At today’s price of $2.90 the Company is valued at approximately $130 million and with revenues approaching $100 million or 1.3 times revenues. The last Craig Hallum report had a fair value of Enzo’s business of $6 per share. When AmpiProbe is approved and into the market that number is projected at $14 per share. There is always risk in the market so the investment is not without risk but if held over time should deliver handsome profits off of today’s price. Items to look forward to by the end of the year would be litigation news and an AmpiProbe decision all of which should have a positive impact on the stock price.



Premier Holding Corporation ( PRHL: 0.06 )* 

Volume on Friday 27,200 shares. Shares Outstanding  189,218,861 


We initiate coverage of the Premier Holding Corporation with an immediate target of $ 0.65, which would be 10x the current closing price which was also the bid price offered mostly at $ 0.07. The deregulated energy business is estimated to be a $ 500 billion+ industry in the U.S. and is estimated to be 5-7 times larger than the lucrative telecom deregulation market launched in the early 1980’s. According to the U.S. Energy Information Administration the deregulated retail electric supply market in the northeast alone is over $ 75 billion annually and the current New York market is approximately $ 7.7 billion.


In February 2013 they purchased 80% of the Power Company ( “TPC” ) which is in the deregulated energy space, a $ 500 billion market. The company offers electricity and gas to consumers in the deregulated energy markets. PRHL through its subsidiaries accumulates residential and commercial clients in deregulated markets from all subsidiaries and cross sells energy and energy efficient products and services. I addition PRHL provides top management and financial support services. They provide two basic deliverables to clients: ( 1 ) Energy alternatives brought about by deregulation that results in lower cost energy and (  2 )  Offer energy efficient solutions that provide savings through utilization of state of the art technologies. When Premier acquired TPC, they had sold 11,000 energy contracts. Today that number is over 100,000 contracts. ( Residential Equivalent Contracts ) On October 28,2014 Premier acquired 85% of Lexington Power and Light, LP&L, which became the third subsidiary.

LP&L receivables are guaranteed by the utility.



Stocks and ETF’s bought over the past few weeks


Fundamental Analysis Stocks To Buy with Stops


The  HDGE declined last week to 11.23 its lowest close since the break-out above 11.04 which was the buy signal and an opportunity to make money while the markets are plummeting.


We bought the HDGE @ 11.04.  HDGE is the BEAR hedge.   We   were  unable to buy  Golar.


We bought  Mosaic  MOS and were stopped out at $ 41.90 for a loss of $ 110 plus commissions.  We  were able to buy  Southwest Air  (LUV ) at 33 and Harley Davidson ( HOG ) at  54.


We bought  Virgin Air ( VA ) at 32.20.


Please check on the previous weekly market letters if there are  questions.


We are long in Diana Shipping at 6.60.  DSX  is looking better and you should  buy now if not  already long .


We bought Bank of America  and continue to like the banking sector.


Symbol Name Business Description PE P/S MV mln Price Buy Limit Stop Loss

Or sold

VA Virgin Air Regional Airlines 7.2 1.0 1.5B 37.64 32.20 29.50
OSIR Osirus Therapeutics Biotechnology 690 9.06 664M 19.69 18.90 18.50 x

Stopped out

LUV Southwest Air Regional Airlines 16 1.15 22.6B 39.47 33 32.31sco
HOG Harley Davidson Consumer Goods 14 1.87 11.6B 54.42 54 52.39sco
ENZ Enzo Biochem Life Sciences NA 1.35 134M  3.04 2.78 2.44x
BAC Bank of America Commercial Bank 10 2.02 165.3B 15.56 16.45 15.22x
HDGE Advisor Shares Ranger Bear ETF 11.11 11.04 X 11.00X
GLNG Golar Liquefied N.G. Hedging NA 30.39 3.14B 34.48 32.44 30.50
DSX Diana Shipping Dry Cargo Shipping N/A 3.7 611  6.81 6.60 5.90

NOTE: This is a Sample Issue Only!



Visit: PrincetonResearch.com/join.htm



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm


Rule 17B Attestations and Disclaimers


Princeton Research, Inc. has approximately 2,581,578 shares of AIVN both free and restricted and represents them for Investor relations. Princeton also has about 40,000 shares of TXGE. Princeton is paid $ 1,500 per month from RMS Medical Products. Princeton has bought 81,100 shares of RMS Medical Products. Princeton was paid $ 2,500 to write a report on Xinergy. Princeton has signed a contract with CBLI to be paid $ 2500 for July and August for investor relations. Princeton has been engaged by Target Energy. No contract is currently in place. Princeton was paid about 500,000 restricted shares of Leo Motors.


When there is no movement in penny stocks, even though there is none or very small losses, we will liquidate ( sold AIVN on stop ) even though we like the company, if money is needed for better opportunities.


We now believe REPR represents upside opportunity. The Target ADR trades at about $ 4.50 in U.S. vs 0.05 in Australia. Princeton owns 400,000 Australia shares and about 900 U.S. ADR’s.


Pursuant to the provisions of Rule 206 (4) of the Investment Advisers Act of 1940, readers should recognize that not all recommendations made in the future will be profitable or will equal the performance of any recommendations referred to in this e-mail issue. Princeton may buy or sell its free-trading shares in companies it represents at any time.




Please Direct All Inquiries To:

Mike King

(702) 650-3000



Charles Moskowitz

 (781) 826-8882



Princeton Research

3887 Pacific Street,

Las Vegas, Nevada 89121





Where To Invest Your Money Now